The importance of inflammatory mechanisms in alzheimer disease

[1]  P. Mcgeer,et al.  The role of the immune system in neurodegenerative disorders , 1997, Movement disorders : official journal of the Movement Disorder Society.

[2]  Rena Li,et al.  Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain , 1997, Brain Research.

[3]  D. Walker,et al.  Neurons express proteins of the classical complement pathway in Alzheimer disease , 1997, Brain Research.

[4]  L. Lue,et al.  Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease , 1997, Neurobiology of Aging.

[5]  P. Mcgeer,et al.  Inflammatory Cytokines in the CNS , 1997 .

[6]  W F Stewart,et al.  Risk of Alzheimer's disease and duration of NSAID use , 1997, Neurology.

[7]  Patrick L. McGeer,et al.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.

[8]  D. Aunis,et al.  Chromogranin a triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells , 1996, Neuroscience.

[9]  A. Metz,et al.  NSAIDs and cognition in Alzheimer's disease , 1996, Neurology.

[10]  A D Roses,et al.  Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.

[11]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[12]  M. Pericak-Vance,et al.  Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs , 1995, Neurobiology of Aging.

[13]  M. Folstein,et al.  Nonsteroidal anti-inflammatory drugs in Alzheimer's disease , 1995, Neurology.

[14]  Morgan Bp.  Physiology and Pathophysiology of Complement: Progress and Trends , 1995 .

[15]  D. Walker,et al.  Activation of Macrophages by Alzheimer β Amyloid Peptide , 1994 .

[16]  W. McDonald,et al.  Inverse association of anti‐inflammatory treatments and Alzheimer's disease , 1994, Neurology.

[17]  A. Kaszniak,et al.  Clinical trial of indomethacin in Alzheimer's disease , 1993, Neurology.

[18]  J. Rogers,et al.  Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease , 1992, Neurology.

[19]  R. Sapolsky,et al.  Hippocampal damage associated with prolonged glucocorticoid exposure in primates , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  D. Scott,et al.  Rheumatold Arthritis and Senile Dementia of the Alzhelmer's Type , 1989 .

[21]  S. Roth,et al.  PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL , 1988, The Lancet.